India-Gambia | Maiden Pharmaceuticals told to halt drug production after Gambian death
State regulators in India have halted production at Maiden Pharmaceuticals after the WHO raised concerns that its cough syrups could be linked to the death of 66 children in the Gambia. Authorities say the company skirted at least 12 quality control rules. Maiden Pharmaceuticals has not commented on the allegations so far. And a nationwide crackdown on the firm is underway, as Ishan Garg reports from New Delhi. Mustapha Manneh is West Africa Regional editor at China Dialogue, based in The Gambia. He joined us on Zoom.
For more news, visit sabcnews.com and also #SABCNews on all Social Media platforms.
![Lil Vodu & Vodu Pill – Клауд Бог [ИзиРеп ft. ИзиКлип]](https://images.videosashka.com/watch/j6-ZwX2t9l8)
